BITC for Health & Longevity - Quick Reference Sheet

BITC for Health & Longevity

Created on 09/07/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5 – Audit

A reactive plant defense chemical from cress and nasturtium. Its appetite for sulfur groups switches on the body's own detoxification genes and irritates surfaces it touches. Fewer repeat bladder and airway infections come from one licensed herbal product tested largely by its maker; slower spread of treated bladder cancer, from observation alone. Purified compound: never given to a person. (Full Review)

Protocol

Licensed fixed-combination approach
4 tablets, 3× daily
The only human-tested route. Each film-coated tablet supplies 200 mg nasturtium herb and 80 mg horseradish root, taken with fluid.
Whole-food approach
Cress, nasturtium or papaya seed
Freeze-dried garden cress sprout powder carries roughly 57 mg glucotropaeolin per gram.
Single versus split dosing
Split, without exception in the human record
Every trial used at least two daily administrations; single large doses concentrate mucosal irritation.
Time to effect
Recurrent Urinary Tract Infection
~90 days
The recurrent-cystitis curves separated over roughly 90 days and widened to 180.
Respiratory Tract Infection
Day 3 to ~84 days
Bronchitis symptom scores diverged from placebo by day 3; prophylaxis ran roughly 84 days.
Clearance of Intestinal Parasites
7 days
Stools cleared of parasites in 76.7% of the seed group versus 16.7% of the honey-only group.

Benefits

Contraindications
  • Active peptic ulcer disease or acute gastric or intestinal ulceration
  • Acute kidney inflammation, including acute glomerulonephritis, or estimated glomerular filtration rate below 30 mL/min/1.73 m²
  • Known allergy to nasturtium, horseradish or other Brassicaceae species
  • Documented iodine deficiency (urinary iodine below 100 µg/L) or untreated hypothyroidism
  • Children under 6 years
  • Pregnancy and lactation
  • Active or recent urothelial carcinoma under surveillance without urologist involvement
Key Interactions
  • CYP2E1 substrates (acetaminophen, ethanol)
  • CYP2A6 substrates (nicotine, letrozole)
  • Warfarin and other vitamin K antagonists
  • Antiplatelet and anticoagulant drugs (clopidogrel, apixaban)
  • Over-the-counter irritants (aspirin, ibuprofen, potassium)
  • Antacids and proton pump inhibitors (omeprazole)
  • Other isothiocyanate supplements (sulforaphane, moringa)
  • N-acetylcysteine and high-dose glutathione precursors
  • Supplements with additive urinary antibacterial action (D-mannose, cranberry, uva-ursi)
  • Iodine, kelp and thyroid hormone replacement
  • Antibiotics for urinary or respiratory infection

Risk & Side Effects

  • High:
  • Medium: Gastrointestinal and mucosal irritation
  • Low: Hypersensitivity reactions; thyroid function interference
  • Speculative: Urinary bladder hyperplasia and tumor promotion in rats; inhibition of drug-metabolizing enzymes; glutathione depletion and pro-oxidant stress; disruption of commensal flora

Monitoring

Marker Target Why
Urinalysis with microscopy (red blood cells, protein) No blood, no protein Sentinel test for the urothelial toxicity seen in rats
Urinary total isothiocyanates No established target; change from own baseline Confirms absorption and delivery to the bladder
TSH 0.5–2.0 mIU/L Detects the iodine-competition effect seen in animals
Free T4 Middle to upper half of the laboratory range Separates a genuine thyroid effect from an isolated TSH drift
Urinary iodine concentration 100–199 µg/L Iodine sufficiency is where the thyroid risk disappears
Creatinine and eGFR eGFR at or above 90 mL/min/1.73 m² Contraindicated below 30 mL/min/1.73 m²
ALT and AST ALT <25 U/L men, <20 U/L women Cleared by hepatic conjugation, so liver strain shows here first

Cadence: Baseline, 4 weeks, 12 weeks, then every 6 to 12 months on repeated prophylaxis courses. Acute short courses need no interval testing.

Qualitative Assessment

  • Gastric comfort — heartburn, burning or nausea after a dose
  • Oral, throat or nasal burning
  • Urinary frequency, urgency, dysuria (pain on urination), interval between episodes
  • Frequency and duration of respiratory infections across a season
  • Skin rash, itching or wheeze
  • Energy levels and cold intolerance